HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,020,406 | -7.1% | 11,391 | -11.7% | 0.17% | -6.7% |
| Q2 2023 | $1,098,476 | +74.7% | 12,902 | +69.8% | 0.18% | +79.0% |
| Q1 2023 | $628,734 | +0.2% | 7,598 | -4.7% | 0.10% | -6.5% |
| Q4 2022 | $627,312 | +11.0% | 7,976 | +4.4% | 0.11% | -7.0% |
| Q3 2022 | $565,000 | +15.5% | 7,638 | +1.7% | 0.12% | +21.1% |
| Q2 2022 | $489,000 | -38.2% | 7,509 | -40.0% | 0.10% | -33.1% |
| Q1 2022 | $791,000 | -34.1% | 12,514 | -44.7% | 0.14% | -33.0% |
| Q4 2021 | $1,201,000 | -10.6% | 22,648 | +19.1% | 0.21% | -16.2% |
| Q3 2021 | $1,343,000 | -3.6% | 19,021 | -9.0% | 0.25% | -1.6% |
| Q2 2021 | $1,393,000 | -3.9% | 20,897 | -49.7% | 0.26% | -27.2% |
| Q3 2014 | $1,450,000 | -1.0% | 41,525 | 0.0% | 0.35% | +4.4% |
| Q2 2014 | $1,465,000 | – | 41,525 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |